Back

Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials

Cardiovascular Research

7 August 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Arjen J Cupido
Arjen J Cupido

Author

John J P Kastelein
John J P Kastelein

Author

You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Webinar
How to treat patients with borderline dyslipidemia
8 February 2023
thumbnail
Congress Presentation
Value of sustained LDL-C lowering: learnings from long-term data
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources